Literature DB >> 35681249

Prolonged durability of extensive contiguous spinal metastasis stabilization in non-small cell lung cancer patients receiving targeted therapy: two case reports and a literature review.

Pilan Jaipanya1, Pongsthorn Chanplakorn2.   

Abstract

MINI-ABSTRACT: In this report, we present two cases of contiguous spinal metastatic disease in non-small cell lung cancer patients who achieved prolonged survival and stable spinal fixation after treatment with EGFR TKIs.

Entities:  

Keywords:  Spinal metastasis; epidermal growth factor tyrosine kinase inhibitor; non-small cell lung cancer; quality of life; spinal cord compression; surgery; targeted therapy

Mesh：

Substances：

Year:  2022        PMID： 35681249      PMCID： PMC9189544          DOI： 10.1177/03000605221105003

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.573


  28 in total

1.  A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiromi Matsuzaki; Hiroshi Oda; Masashi Oshima; Junnosuke Ryu
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-01       Impact factor: 3.468

2.  The SORG nomogram accurately predicts 3- and 12-months survival for operable spine metastatic disease: External validation.

Authors:  Nuno Rui Paulino Pereira; Lily Mclaughlin; Stein J Janssen; Cornelis N van Dijk; Jos A M Bramer; Ilya Laufer; Mark H Bilsky; Joseph H Schwab
Journal:  J Surg Oncol       Date:  2017-03-27       Impact factor: 3.454

3.  Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

Authors:  Makoto Maemondo; Akira Inoue; Kunihiko Kobayashi; Shunichi Sugawara; Satoshi Oizumi; Hiroshi Isobe; Akihiko Gemma; Masao Harada; Hirohisa Yoshizawa; Ichiro Kinoshita; Yuka Fujita; Shoji Okinaga; Haruto Hirano; Kozo Yoshimori; Toshiyuki Harada; Takashi Ogura; Masahiro Ando; Hitoshi Miyazawa; Tomoaki Tanaka; Yasuo Saijo; Koichi Hagiwara; Satoshi Morita; Toshihiro Nukiwa
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

4.  Evaluation of lung cancer metastases to the spine.

Authors:  Ufuk Aydinli; Cagatay Ozturk; Sami Bayram; Sureyya Sarihan; Turkkan Evrensel; Halil Sedat Yilmaz
Journal:  Acta Orthop Belg       Date:  2006-10       Impact factor: 0.500

5.  The CARE guidelines: consensus-based clinical case reporting guideline development.

Authors:  Joel J Gagnier; Gunver Kienle; Douglas G Altman; David Moher; Harold Sox; David Riley
Journal:  Headache       Date:  2013 Nov-Dec       Impact factor: 5.887

Review 6.  The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Yue-Lun Zhang; Jin-Qiu Yuan; Kai-Feng Wang; Xiao-Hong Fu; Xiao-Ran Han; Diane Threapleton; Zu-Yao Yang; Chen Mao; Jin-Ling Tang
Journal:  Oncotarget       Date:  2016-11-29

7.  Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice.

Authors:  Ori Barzilai; Stefano Boriani; Charles G Fisher; Arjun Sahgal; Jorrit Jan Verlaan; Ziya L Gokaslan; Aron Lazary; Chetan Bettegowda; Laurence D Rhines; Ilya Laufer
Journal:  Global Spine J       Date:  2019-05-08

8.  Deep Learning to Predict EGFR Mutation and PD-L1 Expression Status in Non-Small-Cell Lung Cancer on Computed Tomography Images.

Authors:  Chengdi Wang; Xiuyuan Xu; Jun Shao; Kai Zhou; Kefu Zhao; Yanqi He; Jingwei Li; Jixiang Guo; Zhang Yi; Weimin Li
Journal:  J Oncol       Date:  2021-12-31       Impact factor: 4.375

9.  Radiomics combined with clinical characteristics predicted the progression-free survival time in first-line targeted therapy for advanced non-small cell lung cancer with EGFR mutation.

Authors:  Jian-Man Zhu; Lei Sun; Linjing Wang; Tong-Chong Zhou; Yawei Yuan; Xin Zhen; Zhi-Wei Liao
Journal:  BMC Res Notes       Date:  2022-04-14

Review 10.  Diagnostic algorithm, prognostic factors and surgical treatment of metastatic cancer diseases of the long bones and spine.

Authors:  Miklós Szendrői; Imre Antal; Attila Szendrői; Áron Lazáry; Péter Pál Varga
Journal:  EFORT Open Rev       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.